3D printing doxofylline orally disintegrating tablets and preparation method thereof
A doxofylline, 3D printing technology, applied in the direction of pharmaceutical formulations, medical preparations with inactive ingredients, and medical preparations containing active ingredients, etc., can solve the problems of long disintegration time, inability to meet emergency patients, etc. Low toxicity and side effects of drugs, personalized printing, and great curative effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] The prescription is as follows:
[0029]
[0030] 3D printing parameters are as follows:
[0031]
[0032]
[0033] The preparation method is as follows:
[0034] (1) According to the pre-set parameters, use CAD and other software to model, and convert it into an stl format file and import it into the LTY software control system of the 3D printer.
[0035] (2) Calculated by weight percentage, mix doxofylline (50%), sucrose (39%), povidone K30 (10%), and micronized silica gel (1%) evenly in proportion, and load it into 3D printing as a medicine powder In the powder box of the rapid prototyping machine.
[0036] (3) Put 1% povidone K30-50% ethanol solution into the ink cartridge.
[0037] (4) The control system outputs instructions to control the 3D printing rapid prototyping machine to print doxofylline orally disintegrating tablets: the powder spreading device first spreads a layer of powder with a thickness of 0.3mm on the powder bed, and then prints the no...
Embodiment 2
[0042] The prescription is as follows:
[0043]
[0044] 3D printing parameters are as follows:
[0045]
[0046]
[0047] The preparation method is as follows:
[0048] (1) According to the pre-set parameters, use CAD and other software to model, and convert it into an stl format file and import it into the LTY software control system of the 3D printer.
[0049] (2) Calculated by weight percentage, doxofylline (52%), sucrose (30%), low-substituted hydroxypropyl methylcellulose (5%), povidone K30 (10%), micropowder silica gel ( 1%) and sucralose (2%) are uniformly mixed in proportion, and packed into the powder box of the 3D printing rapid prototyping machine as a medicinal powder.
[0050] (3) Put 50% ethanol solution into the cartridge.
[0051] (4) The control system outputs instructions to control the 3D printing rapid prototyping machine to print doxofylline orally disintegrating tablets: the powder spreading device first spreads a layer of powder with a thick...
Embodiment 3
[0056] The prescription is as follows:
[0057]
[0058] 3D printing parameters are as follows:
[0059]
[0060] The preparation method is as follows:
[0061] (1) According to the pre-set parameters, use CAD and other software to model, and convert it into an stl format file and import it into the LTY software control system of the 3D printer.
[0062] (2) Calculated by weight percentage, doxofylline (57%), sucrose (20%), croscarmellose sodium starch (10%), povidone K30 (10%), micronized silica gel (1%) ), stevioside (2%) are mixed evenly in proportion, and packed in the powder box of 3D printing rapid prototyping machine as medicine powder.
[0063] (3) Put 1% povidone K30-50% ethanol solution into the ink cartridge.
[0064] (4) The control system outputs instructions to control the 3D printing rapid prototyping machine to print doxofylline orally disintegrating tablets: the powder spreading device first spreads a layer of powder with a thickness of 0.2mm on the p...
PUM
Property | Measurement | Unit |
---|---|---|
Radius | aaaaa | aaaaa |
Thickness | aaaaa | aaaaa |
Thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com